PYRIDYL DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein: W is -O-, -N(R1)-, C(O) , S(O)t ; (where t is 0, 1 or 2), N(R1)S(O)2 , S(O)2N(R1) , C(O)...

Full description

Saved in:
Bibliographic Details
Main Authors KODUMURU, Vishnumurthy, SUN, Shaoyi, RAINA, Vandna, WINTHER, Michael, D, TU, Chi, KAMBOJ, Rajender, LI, Wenbao, HUDSON, Cindy, J, ABREO, Melwyn, SVIRIDOV, Serguei, GSCHWEND, Heinz, W, LIU, Shifeng, KONDRATENKO, Mikhail, A, ZHANG, Zaihui, SEID BAGHERZADEH, Mehran, HARVEY, Daniel, F
Format Patent
LanguageEnglish
Published 03.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein: W is -O-, -N(R1)-, C(O) , S(O)t ; (where t is 0, 1 or 2), N(R1)S(O)2 , S(O)2N(R1) , C(O)N(R1) or N(R1)C(O)N(R1) ; and V is C(O) , C(S) , C(O)N(R1)-, C(O)O-, S(O)2-, S(O)2N(R1)- or C(R11)H; and x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed. Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein: W is -O-, -N(R1)-, C(O) , S(O)t ; (where t is 0, 1 or 2), N(R1)S(O)2 , S(O)2N(R1) , C(O)N(R1) or N(R1)C(O)N(R1) ; and V is C(O) , C(S) , C(O)N(R1)-, C(O)O-, S(O)2-, S(O)2N(R1)- or C(R11)H; and x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Bibliography:Application Number: TN2006SN00036